The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Mechanisms of vancomycin resistance in Staphylococcus aureus
Open accessAbstract
Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-positive bacterial infections. Traditionally, it has been used as a drug of last resort; however, clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) strains with decreased susceptibility to vancomycin (vancomycin intermediate-resistant S. aureus [VISA]) and more recently with high-level vancomycin resistance (vancomycin-resistant S. aureus [VRSA]) have been described in the clinical literature. The rare VRSA strains carry transposon Tn1546, acquired from vancomycin-resistant Enterococcus faecalis, which is known to alter cell wall structure and metabolism, but the resistance mechanisms in VISA isolates are less well defined. Herein, we review selected mechanistic aspects of resistance in VISA and summarize biochemical studies on cell wall synthesis in a VRSA strain. Finally, we recapitulate a model that integrates common mechanistic features of VRSA and VISA strains and is consistent with the mode of action of vancomycin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phenotypically, hVISA/VISA strains exhibit distinct metabolic characteristics that may include i) increase in fructose utilization, ii) increased fatty acid metabolism, iii) impaired acetate metabolism and tricarboxylic acid cycle, iv) decrease in glutamate availability, and iv) increase expression of cell wall synthesis genes.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“However, the available evidence shows that the regulatory systems most consistently implicated in this mechanism of resistance are YycFG (WalKR), VraSR (homolog of LiaFSR), and GraRS (104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“These global homeostatic changes appear to lead to a reduced autolytic activity with thickened cell wall and an increase amount of free D-Ala-D-Ala dipeptides with less peptidoglycan cross-linking (101, 104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“In addition, VISA strains bind vancomycin more avidly than their non –VISA counterparts, however, diffusion of the antibiotic molecule into the inner part of the cell wall appears to be impaired.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“Finally, a striking feature of many hVISA/VISA strains is the ability to revert from one phenotype to another (or even to a fully vancomycin susceptible phenotype) in the absence of vancomycin exposure.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Emergence of Vancomycin Resistance inStaphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,086
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Levine, D. P. (2005) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 883
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 761
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 692
Sieradzki, K., Roberts, R. B., Haber, S. W., & Tomasz, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400704 · Cited by 638
Self-citationMwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de LENCASTRE, H., Richardson, P., Bruce, D. G., Rubin, E. M., Myers, E. W., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
Self-citationReemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. “. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 522
Kuroda, M., Kuroda, H., Oshima, T., Takeuchi, F., Mori, H., & Hiramatsu, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03599.x · Cited by 515
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–567 of 567
Vancomycin-resistente Enterokokken
Dettenkofer, M., & Schulz-Stübner, S. (2023) · Springer eBooks · doi:10.1007/978-3-662-65708-9_6
Staphylococcus Infections and Emerging Drug Resistance: A Global Concern
Juneja, S., Kalia, R., Singh, R. P., & Roy, V. (2023) · Journal of Medical Academics · doi:10.5005/jp-journals-11003-0124
Super SKAPE: La Problemática de las Superbacterias
Diel, F. (2023) · Epicentro - Revista de Investigación Ciencias de la Salud · doi:10.59085/2789-7818.2023.75
FITOTERÁPICOS DERIVADOS DA ESPÉCIE CORYMBIA CITRIODORA: REVISÃO LITERÁRIA
Silva, G. F. A., Gomes, V. E. B. D. O., Magalhães, C. F. C. B., Araújo, L. M. D. S., Magalhães, M. K. A., Silva, T. D. D. S., Assunção, T. G., de Araújo, M. D. F. S., Silva, W. F. D. S., & de Oliveira, G. A. L. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_005
ALTERAÇÕES FISIOLÓGICAS CAUSADAS PELA UTILIZAÇÃO DE MEDICAMENTOS PSICOFÁRMACOS
Damasceno, R. A. R., dos Santos, T. F., Machado, R. S. D. A., & de Oliveira, G. A. L. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_001
Soares, A. L. O., Barreto, C. S. S., Soares, E. E. N., Soares, I. L. M. M., de Carvalho, M. U. W. B., & de Oliveira, K. B. V. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_004
Carvalho, G. C. G., Leal, I. M. M., Bastos, L. A., Alves, L. D. S., Meneses, A. P. R. D. S. A., de Matos, D. D. M., Rebêlo, E. M. G., Santos, J. S., de Oliveira, K. B. V., & de Carvalho, M. U. W. B. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_002
PANORAMA ATUAL DA PRODUÇÃO CIENTÍFICA SOBRE PIOMETRA CANINA
Lopes, M. M., & Rodrigues, F. M. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_008
PERFIL EPIDEMIOLÓGICO DE SÍFILIS CONGÊNITA NO ESTADO DO PIAUÍ: UM RECORTE TEMPORAL DE 10 ANOS
Meneses, A. P. R. D. S. A., Matos, D., Rebêlo, E. M. G., Santos, J. S., Carvalho, G. C. G., de Carvalho, M. U. W. B., & de Oliveira, K. B. V. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_009
BACTÉRIA MULTIRRESISTENTE: UM DESAFIO PARA O SISTEMA DE SAÚDE
Glicério, M. F. G., Junqueira, L. C. D. S., Garcia, A. V. D. O., & Cursino, L. M. L. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_003
IMPORTÂNCIA CLÍNICA DE STENOTROPHOMONAS MALTOPHILIA: REVISÃO NARRATIVA DA LITERATURA
Fumian, V. A. F., Cucinelli, A. D. E. S., Souza, C. R. V. D. M., & Chagas, T. P. G. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_006
MICROBIOLOGIA, PARASITOLOGIA E IMUNOLOGIA: ABORDAGENS CLÍNICAS, PRÁTICAS E EPIDEMIOLÓGICAS
Inovar, E. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4
INVASÃO NEUTRÓFILA NA HIDRADENITE SUPURATIVA: MECANISMOS E IMPLICAÇÕES CLÍNICAS
Torreão, A. O. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-216-4_007
Belete, M. A., Gedefie, A., Alemayehu, E., Debash, H., Mohammed, O., Gebretsadik, D., Ebrahim, H., & Tilahun, M. (2023) · Figshare · doi:10.6084/m9.figshare.24062403
Zhang, Y., Zhang, Y., Chen, C., Cheng, H., Deng, X., Li, D., Bai, B., Yu, Z., Deng, Q., Guo, J. Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19664380
Characteristics of Laboratory-Derived Vancomycin-Intermediate Staphylococcus aureus Strains
Jongutsa, S., Trakulsomboon, S., Pannanusorn, S., Chanklan, R., Chantorn, S. T., Surarit, W., Traijitt, T., & Utaida, S. (2024) · Journal of Current Science and Technology · doi:10.59796/jcst.v14n2.2024.21
Saima, S., Sharma, H. K., Latha, S., Lather, V., Tewari, D., Sharma, R., Jain, G. K., Pandita, D., & Kumar, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4380132/v1
Kaur, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4614235/v1
Olotu, T. M., Gumi, A. S., Ogundolie, F. A., & Jamiu, A. M. (2024) · International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG) · doi:10.1109/seb4sdg60871.2024.10630041
Salman, I. M. A., Khazaal, S. S., & Al–Alak, S. K. (2023) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000347
Hamzeh, S., Hosseini, S. R., Javaheri, T., & Rajabi, N. (2024) · Research in Biotechnology and Environmental Science · doi:10.58803/rbes.v3i4.52
Chen, W., Wang, J., Chang, C.-C., & Lin, Y. E. (2025) · Microorganisms · doi:10.3390/microorganisms13010101
Sandim, G. C., Sardi, J. D. C. O., da Silva, A. C. B., Lima, L. S., Parisotto, E. B., Crusca, E., Jacobowski, A. C., & Macedo, M. L. R. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10571-w
Vancomycin intermediate and vancomycin resistant Staphylococcus aureus: an upcoming threat
Patel, A. S., Bhabhor, U., & Mullan, S. A. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20252022
Glycopeptide Antibiotics in the Era of Resistance: An Updated Overview
Reddy, T. P., Chakravarthy, U., Baandhavi, S. P., & Harshitha, T. (2025) · doi:10.38124/ijisrt/25jul1107
Impact of Fixed Orthodontic Appliances on Staphylococcus aureus and Candida albicans
Aljbouri, M., Al-Dabbagh, N. N., & Al-Khafaji, T. J. (2025) · Dentistry 3000 · doi:10.5195/d3000.2025.975
A novel two-component system controls vancomycin resistance in epidemic Clostridioides difficilePreprint
Buddle, J. E., Pennington, V. K., Kirk, J. A., Faber, F., Turner, C. E., Brockhurst, M. A., & Fagan, R. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.21.671617
Nascimben, M., & Rimondini, L. (2025) · Current Microbiology · doi:10.1007/s00284-025-04435-3
Goudarzi, M., Raigani, M., Salehi, Z., Navidinia, M., Nasiri, M. J., & Goudarzi, H. (2025) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2025.02639
Karcher, R., Smith, L. S., & Rastogi, V. K. (2025) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2025.107275
Vedeneev, P. A., Buhler, A., Lebedeva, I. A., & Kovaleva, E. G. (2025) · Siberian Journal of Life Sciences and Agriculture · doi:10.12731/2658-6649-2025-17-3-1131 · Cited by 1
A rapid point-of-care test for vancomycin monitoring at the clinical bedside
Burrow, D. T., Kinnamon, D., Liu, J. X., Heggestad, J. T., Wall, S. A., Silverstein, B. E., Mithani, S. K., Krishnamoorthy, V., Drew, R. H., Joh, D. Y., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116064
The profile of the resistance of Staphylococcus aureus against selected antibiotics in Najaf
Kadhim, S., Ismaeel, G. L., AbdulHussein, A. H., Najaf, H. N., & Oleiwi, Z. K. (2025) · Polski Merkuriusz Lekarski · doi:10.36740/merkur202505108
Additional file 1 of Antibacterial activity and mechanisms of D-3263 against Staphylococcus aureus
Liu, X., Xiong, Y., Peng, R., Zhang, Y., Cai, S., Qiwen, D., Yu, Z., Wen, Z., Chen, Z., & Hou, T. (2024) · Figshare · doi:10.6084/m9.figshare.26113006
Additional file 2 of Antibacterial activity and mechanisms of D-3263 against Staphylococcus aureus
Liu, X., Xiong, Y., Peng, R., Zhang, Y., Cai, S., Deng, Q., Yu, Z., Wen, Z., Chen, Z., & Hou, T. (2024) · Figshare · doi:10.6084/m9.figshare.26113075
Belete, M. A., Gedefie, A., Alemayehu, E., Debash, H., Mohammed, O., Gebretsadik, D., Ebrahim, H., & Tilahun, M. (2023) · Figshare · doi:10.6084/m9.figshare.24062400
Zhang, Y., Zhang, Y., Chen, C., Cheng, H., Deng, X., Li, D., Bai, B., Yu, Z., Qiwen, D., Guo, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19664377
Abdelraheem, W. M., Khairy, R. M. M., Zaki, A. I., & Zaki, S. H. (2021) · Figshare · doi:10.6084/m9.figshare.16305519
Zhang, Y., Zhang, Y., Chen, C., Cheng, H., Deng, X., Li, D., Bai, B., Yu, Z., Qiwen, D., Guo, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19664374
Sony, S., & Sahira, H. (2025) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000453
Mahajan, A., Khan, H. Z., Kavuri, R., & Ruhela, A. (2026) · Cureus · doi:10.7759/cureus.101645
Yılmaz, Ö. T., & Hızlısoy, H. (2019) · DergiPark (Istanbul University)
AMP-36 exhibits potent therapeutic efficacy against MRSA pneumonia through membrane-target mechanism
Han, Y., Wang, Y., Cheng, L., Sun, C., Song, J., Zhang, X., Zhang, X., Jiang, Y., Li, X., Kong, D., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-44156-6
Molecular mechanisms of antimicrobial resistance
Mukherjee, D., Ghosh, P., Sen, D., & Chakravortty, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00004-7
Actinomycetes metabolites and its application for pharmaceutical industry
Gogoi, D., Sen, S., Dutta, P. P., & Gogoi, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36411-2.00018-7
sRNA-controlled iron-sparing response in Staphylococci
Coronel‐Tellez, R. H. (2021) · theses.fr (ABES) · doi:10.70675/5b8238b7z4e5ez44d9za2a5z92e6bb344194
Mabandza, B. D. B. (2024) · theses.fr (ABES) · doi:10.70675/9ae1dd65z81c2z4558z93e5zf2b97f4efecf
Shaik, M. S., Jerra, V. S., Ramachandran, B., & Venkatesan, S. (2026) · Journal of Peptide Science · doi:10.1002/psc.70098
Wei, X., Zhang, R., Liao, J., Liu, H., Hu, Z., Shang, W., Wang, J., Li, M., Rao, X., & Lu, S. (2026) · Virus Research · doi:10.1016/j.virusres.2026.199745
Cheng, Q., Liu, L., Liu, C., Xie, F., Dong, J., Qin, X., Huang, S., Li, X., Kou, X., Deng, H., et al. (2026) · Advanced Science · doi:10.1002/advs.75541
Zhang, L., An, H., Wen, B., Lai, L., Rong, X., Zheng, H., Chen, Y., Jiang, C., Lu, C., Yang, W., et al. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108596
Giuliano, S., Cojutti, P. G., Bulfoni, M., Cotrufo, M., Curcio, F., Gualandi, N., Lombardo, C., Moreal, C., Pea, F., Tascini, C., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107877
Vancomycin population pharmacokinetics in patients with burns
Shi, Y., Yao, Y., He, X., Bian, X. L., Yu, X., Fang, J., Wang, H. B., & Dou, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1829805
Hu, P., Lu, M., Cassandre, N. H., Chen, P., Liu, H., & Shi, Y. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128652
Hoo, W. P. Y., Gullick, J., Leung, R. F., Fulcher, A. J., Cass, R. W., Tailhades, J., Peleg, A. Y., Payne, J. A. E., O’Keeffe, M. A., & Cryle, M. J. (2026) · ChemBioChem · doi:10.1002/cbic.70495
Saturated fatty acids enhance daptomycin activity in a Fak-dependent manner in enterococci
Maharjan, S., Getty, T. A., Dickens, Q., Hughes, A. L., Rundle, J., & Fozo, E. M. (2026) · Microbiology · doi:10.1099/mic.0.001751
Antimicrobial Resistance in Major Gram-Positive Pathogens: Beyond the Vancomycin Border
Papageorgiou, D., & Akinosoglou, K. (2026) · Antibiotics · doi:10.3390/antibiotics15080780
The Impact of Peptidoglycan Structure on Immune Sensing
Cardozo, S., & Skerry, C. M. (2026) · Toxins · doi:10.3390/toxins18080354
Sobrinho, J. D. D. S., de Medeiros, A. B. M., Diniz, L. A. S., de Souza, M. A. A., Silva, M. L. C. R., Castro, V., Nassar, A. F. D. C., Neto, R. S. C., de Carvalho, A. F., de Azevêdo, S. S., et al. (2026) · Brazilian Journal of Biology · doi:10.1590/1519-6984.307275
Boutefnouchet, C., Berredjem, H., Aouras, H., & Diene, S. M. (2026) · Molecular Genetics and Genomics · doi:10.1007/s00438-026-02505-0
Implications of oxidative stress on microbial evolution
Kumari, A., & Singh, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-42857-9.00015-3
Longchar, A., Thekkumkara, S., Palanisamy, S., Kanthalal, S. K., Venkidasamy, B., Thiruvengadam, R., Rekha, A., Thiruvengadam, M., & Sankaran, S. (2026) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-026-00925-2
Hickok, N. J., Ketonis, C., & Adams, C. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10153-5
Chen, R., Guo, L.-Y., Deng, Y., Zhuang, Y., Cheng, Y., & Xu, Y. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00547-26
Metadata
- Authors
- Gardete, S., & Tomasz, A.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Tomasz, Alexander
- Venue
- Journal of Clinical Investigation
- Published
- 2014-07-01
- Volume
- 124
- Issue
- 7
- Pages
- 2836-2840
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4071404
- OpenAlex
- W1983784984
- Cited by
- 565
- References
- 66
- Citations by year
- 2026: 26 · 2025: 53 · 2024: 71 · 2023: 48 · 2022: 53 · 2021: 57 · 2020: 49 · 2019: 66 · 2018: 40 · 2017: 43 · 2016: 29 · 2015: 25 · 2014: 4
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (2 R01 AI457838-14)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- vancomycin resistance, Staphylococcus aureus, vancomycin-intermediate Staphylococcus aureus, vancomycin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Tn1546 transposon, vancomycin-resistant Enterococcus faecalis, cell wall biosynthesis, glycopeptides, antibiotic resistance mechanisms, cell wall metabolism
- MeSH terms
- Cell Wall, DNA Transposable Elements, DNA, Bacterial, Genes, Bacterial, Humans, Microbial Sensitivity Tests, Models, Biological, Mutation, Staphylococcal Infections, Staphylococcus aureus, Virulence, Vancomycin Resistance, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
